114414-17-4 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Amino-3-hydroxy-4-bromopyridine HBR is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into the molecular structures of various drugs, enhancing their therapeutic properties and effectiveness.
Used in Agrochemical Production:
In the agrochemical industry, 2-Amino-3-hydroxy-4-bromopyridine HBR is utilized as a building block for the development of new agrochemicals, contributing to the creation of innovative products with improved performance in crop protection and plant growth regulation.
Used in Organic Compounds Synthesis:
2-Amino-3-hydroxy-4-bromopyridine HBR serves as a valuable precursor in the synthesis of a wide range of organic compounds, including those with potential applications in materials science, chemical engineering, and other related fields.
Used in Functional Materials Development:
2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR is employed as a component in the production of functional materials, where its unique structural features and properties can be leveraged to create materials with specific characteristics, such as improved conductivity, catalytic activity, or sensing capabilities.
Used in Research and Development:
2-Amino-3-hydroxy-4-bromopyridine HBR is utilized in research and development settings to explore its potential biological and pharmacological activities, making it a subject of interest for further study in the fields of medicine and drug discovery, with the aim of identifying new therapeutic agents and understanding their mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 114414-17-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,4,1 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 114414-17:
(8*1)+(7*1)+(6*4)+(5*4)+(4*1)+(3*4)+(2*1)+(1*7)=84
84 % 10 = 4
So 114414-17-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H5BrN2O.BrH/c6-3-1-2-8-5(7)4(3)9;/h1-2,9H,(H2,7,8);1H
114414-17-4Relevant articles and documents
POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES
-
Page/Page column 154, (2021/01/29)
The current invention provides urea derivatives, in particular compounds having the core structure heteroaryl-NH-CO-NH-aryl-O- heteroaryl, for use in treating, ameliorating, delaying, curing and/ or preventing a disease or condition associated with muscle cells and/or satellite cells, such as Duchenne muscular dystrophy, Becker muscular dystrophy, cachexia or sarcopenia.
MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
Page/Page column 125, (2018/03/25)
The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).
NOVEL INHIBITORS OF MAP4K1
-
Page/Page column 53, (2018/12/13)
The invention relates to novel inhibitors of MAP4K1 (HPK1) useful for the treatment of diseases or disorders characterised by dysregulation of the signal transduction pathways associated with MAPK activation, including hyperproliferative diseases, diseases of immune system dysfunction, inflammatory disorders, neurological diseases, and cardiovascular diseases. The invention further relates to pharmaceutical compositions comprising the same and methods of treatment of said diseases and disorders. The inhibitors are of formula (I) wherein the definitions for A, D, E, F, R5, R6, R7, Z, ring Q, n, x and y are as given in the application.
